Last edited by Gulrajas
Thursday, July 23, 2020 | History

3 edition of AMARILLO BIOSCIENCES, INC. found in the catalog.

AMARILLO BIOSCIENCES, INC.

ICON Group Ltd.

AMARILLO BIOSCIENCES, INC.

Labor Productivity Benchmarks and International Gap Analysis (Labor Productivity Series)

by ICON Group Ltd.

  • 6 Want to read
  • 19 Currently reading

Published by Icon Group International .
Written in English

    Subjects:
  • General,
  • Human Resources.,
  • Company Study,
  • Forecasting,
  • Statistical Analysis,
  • Labor Productivity,
  • Financial Analysis,
  • Business / Economics / Finance

  • The Physical Object
    FormatRing-bound
    Number of Pages20
    ID Numbers
    Open LibraryOL10846653M
    ISBN 100597425000
    ISBN 109780597425004

    Amarillo Biosciences Inc's Current Key Valuation Ratios, PE, PB, PCF, PS, compare to Biotechnology & Drugs Industry and Healthcare Sector. Amarillo Biosciences, Inc. engages in the discovery and development of pharmaceutical and biotech products. It operates through the following divisions: Pharmaceutical, Medical and Consumer. The company was founded by Joseph M. Cummins in June and is headquartered in Amarillo, TX.

    Find tb testing in Amarillo, TX on Yellowbook. Get reviews and contact details for each business including videos, opening hours and more. Amarillo Biosciences Inc. Sw 9th Ave. Amarillo, TX Map () Send Email Clinical, medical & diagnostic laboratories. Website; Quick Info.   Amarillo Biosciences, Inc. has identified certain goals for its future business development, and wishes to share this information with both its shareholders and the general public. ABI recognizes.

      Amarillo Biosciences, Inc. is a U.S. biotechnology firm operating in global partnership with the Hayashibara Group, which also holds 7% of Amarillo Biosciences shares and has provided over $18 million in loans, grants and equity investments. The company valuation of Amarillo Biosciences Inc. according to these metrics is way below the market valuation of its peer group. The P/Earnings NTM ratio of Amarillo Biosciences Inc. is significantly lower than the average of its sector (Pharmaceuticals):


Share this book
You might also like
INMEDICA DEVELOPMENT CORP.

INMEDICA DEVELOPMENT CORP.

small business executive evaluates business education

small business executive evaluates business education

Developing students, developing faculty : incompatable or compatable goals?

Developing students, developing faculty : incompatable or compatable goals?

Gas turbines

Gas turbines

John Godfreys Fortunes

John Godfreys Fortunes

Josephine Foote Fairfax.

Josephine Foote Fairfax.

Kiss me at the stroke of midnight

Kiss me at the stroke of midnight

Muscle medicine

Muscle medicine

Impolite comedy

Impolite comedy

Fundamentals in chemical process calculations

Fundamentals in chemical process calculations

methodology of the longitudinal study of social, economic, and demographic change.

methodology of the longitudinal study of social, economic, and demographic change.

Money against crime

Money against crime

Chest Disease

Chest Disease

Thermal analysis.

Thermal analysis.

AMARILLO BIOSCIENCES, INC by ICON Group Ltd. Download PDF EPUB FB2

Amarillo Biosciences, Inc. (ABI) Amarillo, Texas, US. Amarillo Biosciences, Inc. (ABI), is a diversified healthcare company engaged in the discovery and development of novel biopharmaceuticals, technologically innovative medical treatments, and.

Stock analysis for Amarillo Biosciences Inc (AMAR:OTC US) including stock price, stock chart, company news, key statistics, fundamentals and company ees: 2. q: amarillo biosciences inc May. 17, at p.m. ET on Edgar Online - (EDG = 10Q, 10K) Amarillo Biosciences Inc (AMAR) President, CEO &.

Amarillo Biosciences Inc. balance sheet, income statement, cash flow, earnings & estimates, ratio and margins. View AMAR financial statements in ees: 6.

Amarillo Biosciences Inc (OTCMKTS:AMAR) posted its earnings AMARILLO BIOSCIENCES on Wednesday, November, 14th. The company reported ($) earnings per share (EPS) for the quarter.

The firm had revenue of $ million for the quarter. Amarillo Biosciences had a negative return on equity of % and a negative net margin of 12,%.

Amarillo Biosciences, Inc. is engaged in the business of biopharmaceutical research and development. The Company develops biologics for the treatment of human and animal diseases.

The Company's focus is research aimed at the treatment of human disease indications, particularly influenza, hepatitis C, AMARILLO BIOSCIENCES and other indications using. JOSEPH M.

CUMMINS has been Chairman, President and Chief Executive Officer of Amarillo Biosciences, Inc., since August Dr. Cummins was Chairman of the Board, Amarillo Cell Culture Co., Inc. Find real-time AMAR - Amarillo Biosciences Inc stock quotes, company profile, news and forecasts from CNN Business.

Peg Ratio (TTM) is a widely used stock evaluation measure. Find the latest Peg Ratio (TTM) for Amarillo Biosciences Inc. (AMAR). Amarillo Biosciences, Inc. engages in developing biologics for the treatment of human and animal diseases.

It focuses on research aimed at the treatment of human disease indications, particularly. Description. Amarillo Biosciences Inc is engaged in developing biologics for the treatment of human and animal diseases.

The company mainly focuses on the research of the treatment of human disease indications, particularly influenza, hepatitis C, thrombocytopenia, and other indications using natural human interferon-alpha that is administered in a proprietary low dose. Stock analysis for Amarillo Biosciences Inc (AMARD) including stock price, stock chart, company news, key statistics, fundamentals and company ees: 4.

Amarillo Biosciences, Inc. (AMAR) Related Stocks - discover similar stocks, compare dividends and return. Compare momentum and price performance. Amarillo Biosciences, Inc. is engaged in the business of biopharmaceutical research and development.

The Company develops biologics for the treatment of human and animal diseases. The Company's. Amarillo Biosciences, Inc. (the "Company” or “ABI”) is a Texas corporation formed in engaged in developing biologics for the treatment of human and animal diseases.

Find out all the key statistics for AMARILLO BIOSCIENCES (AMAR), including valuation measures, fiscal year financial statistics, trading record, share statistics and more. Get directions, reviews and information for Amarillo Biosciences Inc in Amarillo, TX.

Amarillo Biosciences Inc SW 9th Ave Amarillo TX Reviews () Website. Book Hotels, Flights, & Rental Cars; Relaunch tutorial hints NEW. Share or Embed Map. AMAR: Amarillo Biosciences Inc. Detailed Estimate. Get the latest Detailed Estimate from Zacks Investment Research. AMAR has a ROC (Joel Greenblatt) % of ,% as of today().

In depth view into Amarillo Biosciences ROC (Joel Greenblatt) % 1/5. Amarillo Biosciences, Inc. was incorporated in June in the State of Texas under the name of Amarillo Cell Culture Company, Incorporated.

In Maywe changed our name to Amarillo Biosciences, Inc. Our principal executive offices are located at Business Park Drive, Amarillo, Texas Our Telephone number is (). Description: Amarillo Biosciences Inc is engaged in developing biologics for the treatment of human and animal diseases.

The company mainly focuses on the research of the treatment of human disease indications, particularly influenza, hepatitis C, thrombocytopenia, and other indications using natural human interferon-alpha that is administered.Company Name: Amarillo Biosciences Inc., Stock Symbol: AMAR, Industry: Biotechs, Total Posts:Last Post: 1/10/ PM.

Amarillo Biosciences, Inc. (ABI) (OTCBB: AMAR) today issued the following Progress Report: Hepatitis C: CytoPharm, Inc., ABI's strategic partner in Taiwan is funding a Phase 2 clinical trial of patients with chronic hepatitis C virus of the end of Octoberpatients have already been enrolled with full enrollment expected by early .